Get Our Free Research Email
Conference Calendar 
May 20-23 - Current Concepts in Joint Replacement Spring 2012
May 23-25 - 13th EFORT Congress 2012
Complete Calendar »
|
Orthopedic and Dental Industry News
August 2007
Earnings Globus Medical announced 2Q:07 revenues of $30.2 million, an increase of 52% over the comparable quarter. The company attributes the revenue growth to the expansion of its sales and distribution footprint, product introductions in its fusion, MIS and biomaterials... more
Researchers at the University of Arkansas, Fayetteville developed a nanowire coating that could prove to be a simple, inexpensive method for increasing adhesion of tissue to hip, dental and other implants. The process of preparing the coating is simple: an... more
The interview below was first published in ArgoSpine News in December 2006. As part of our sponsorship of ArgoSpine, we're republishing select ArgoSpine News content for our audience. In this entry, Dr. Ueyama discusses spinal stenosis, his practice in Japan... more
Earnings aap Implantate announced 38% growth in revenues following its consolidation with Fame Medical Group. Revenues in 1H:07 totaled EUR 12.7 million. Highlights from 2Q:07 include a reported double-digit increase in international sales in the Trauma & Joint Reconstruction segment... more
Our own John Chopack Jr. is featured in the July/August issue of Orthopedic Design & Technology. We've republished the article for you here. Car manufacturers pitch their latest vehicles’ ability to go from zero to 60 mph in just five... more
Yesterday, the Philadelphia Inquirer (article here) reported that Synthes and Globus have settled their long running legal dispute for an undisclosed amount. The agreement stipulates that Globus that it will not solicit or hire Synthes employees for one year. This... more
IsoTis announced this morning that the Accell family of products has been granted 510(k) approval by the FDA as a Class II device. The clearance follows nearly a year of back-and-forth between IsoTis and the FDA over the nature of... more
Earnings BioMimetic Therapeutics reported a 2Q:07 net loss of $6.4 million, or $(0.35) per share, beating estimates of $(0.39) per share and improving from a net loss of $3.9 million, or $(0.42) per share, in 2Q:06. 2Q:07 Revenues were $0.5... more
While the stock market takes a licking, ortho keeps on ticking. We have been getting a lot of questions lately about how this summer's credit meltdown and the associated stock market decline has effected orthopedic stocks. Our answer goes right... more
CMS released its final decision on lumbar artificial disc replacement (LADR) procedures yesterday. As we predicted, the final decision does not deviate from the proposed decision, with CMS finding that LADR is not reasonable and necessary for the Medicare population... more
Despite randomized clinical trials' status as the most scientifically rigorous of potential research designs, RCTs make up a relatively small percentage of published orthopedics research. More randomized trials are being conducted now than in the past, but ongoing concerns about... more
Earnings Biologics: Orthovita reported 2Q:07 revenues of $14.85 million, beating estimates of $14.13 million and reflecting a 33% increase over 2Q:06. Sales growth was attributed to increased U.S. sales of VITOSS® FOAM and VITAGEL® products. Net loss decreased to $3.17... more
This morning Integra LifeSciences and IsoTis announced that Integra plans on acquiring IsoTis in an all-cash transaction valued at approximately $51 million plus debt (~$6 million) assumed at closing. Isotis' 2006 revenues were $40.7 million. The $7.25 offered per share... more
In the past few years, specialty hospitals have been the subject of controversy, criticized for accepting only the most profitable patients with the lowest risk of complications and for their lack of emergency and charity care. However, a retrospective study... more
Earnings Large Joint: Exactech announced 2Q:07 revenue of $31.6 million, beating estimates of $29.9 million and up 19% from the comparable quarter. CEO Bill Petty attributed the growth to "acceptance of our new products and continuing success of our products... more
CMS released its final rule for the FY2008 Inpatient Prospective Payment System (IPPS). As we noted when the draft rule was announced in April, ortho payments will mostly increase next year. The rule also confirms that CMS will implement new... more
Complete Archive
|
